Leading Change

Kristina Box, MD, FACOG

Indiana State Health Commissioner

Dr. Kristina Box was named Indiana State Health Commissioner by Governor Eric J. Holcomb on September 18, 2017. She brings to the role a passion for improving the health of Hoosiers, beginning before birth.

Dr. Box has been a practicing obstetrician and gynecologist in Indianapolis for 30 years, starting her career at Community Hospitals of Indianapolis in 1987 as a private practitioner with Clearvista Women's Care. Since 2015, she has served as the Physician Lead for Community Health Network's Women's Service Line. In this role, she built the first multi-disciplinary women’s center in the Community Health Network, developed critical partnerships with area children’s hospitals to improve care and decrease health care costs, and led efforts to ensure that low-income women receive the important free health screenings they need.

She has served on the Indiana Perinatal Quality Improvement Collaborative (IPQIC), an advisory council to the Indiana State Department of Health that is comprised of more than 300 statewide community professionals working to reduce infant mortality. Her work with IPQIC includes serving on a state task force to address neonatal abstinence syndrome (NAS), which established standards for the diagnosis of NAS and developed a hospital study to determine the prevalence of drug exposed newborns.

Dr. Box earned her undergraduate degree at Indiana University in Bloomington and her medical doctorate at Indiana University School of Medicine in Indianapolis. She is a member of several professional organizations, including the Indiana State Medical Association and the Marion County Medical Association, and serves on many hospital committees.

Dr. Box has been involved in ongoing surgical medical missions to Haiti and Bolivia for more than a decade.

She and her husband of 35 years, David, a retired ophthalmologist, live in Indianapolis. They have four adult children.

Wayne Burris

Senior Vice President and Chief Financial Officer, Roche Diagnostics Corporation

Wayne Burris was named Senior Vice President and Chief Financial Officer in 1996 and continues in this role for Roche Diagnostics Corporation. He is a member of the Global Roche Diagnostics Finance Operating Committee. With a strong background in domestic and international accounting and finance, as well as experience dealing with a broad set of business, finance and reporting issues, Burris provides advice for Roche’s various diagnostics businesses.

Burris was founding member of the Roche Diagnostics-North American STAR initiative that generated more than $100 million in purchasing savings and has since become a global initiative. He has served on the Diagnostics Investment Committee, charged with deciding how to allocate and approve more than $500 million in annual capital investments. Burris led a team chartered by Roche Group Corporate Finance to prepare an analysis of the value drivers for the diagnostics business and how these drivers can be better leveraged to gain market share and improve profitability. He has made several presentations at the global Diagnostics Finance Managers meeting including “The Role of the Finance Manager in Driving Business Value.” Prior to his current position, Burris was head of Global Finance for Diabetes Care Business Area and Vice President of Finance. Before joining Roche Diagnostics in 1986, Burris was a Senior Manager for Price Waterhouse LLP with a focus on clients in the financial service industry and global healthcare manufacturers in diagnostics, orthopedics and pharmaceuticals.

Burris currently serves on the board of directors of BioCrossroads.

Daniel Evans, Jr.

Former Chief Executive Officer, Indiana University Health

Dan Evans is the former Chief Executive Officer of Indiana University Health, Indiana’s most comprehensive academic health center and one of the busiest hospital systems in the United States. Through its partnership with Indiana University School of Medicine – one of the nation’s largest medical schools and a global leader in medical education and research – IU Health is uniquely positioned to provide leading edge care and the most skilled clinical teams.

Since IU Health’s inception in 1997, Evans was active on its board of directors and served as its Chairman from 2000 – 2002. He previously served on and chaired the Methodist Hospital board of directors.

Prior to December 2002, Evans was a partner with Baker & Daniels, a law firm of more than 370 professionals with offices around the world.

Evans serves on numerous community, academic and healthcare-related boards and advisory committees, including Indiana Health Information Exchange, Central Indiana Corporate Partnership, BioCrossroads, the University Health System Consortium, United Way of Central Indiana, the Indiana Hospital Association, the Indianapolis and Indiana Chambers of Commerce, and the U.S. Chamber of Commerce.

Evans is a member of the American College of Healthcare Executives and the bars of Indiana, the 7th Circuit and the U.S. Supreme

John C. Lechleiter, PhD

Former Chief Executive Officer, Eli Lilly and Company

Dr. Lechleiter joined the Board on Director's in April 2018 after retiring as CEO of Eli Lilly and Company in 2016 and finishing his role as chairman of Lilly's Board of Directors in May 2017. It was his call to action in a 2012 speech at the BioCrossroads Indiana Life Sciences Summit, that lead to the establishment of the Indiana Biosciences Research Institute.

Lechleiter earned a bachelor’s degree in chemistry from Xavier University and master’s and doctoral degrees in organic chemistry from Harvard University. He has received honorary doctorates from Marian University, the University of Indianapolis, the National University of Ireland, Indiana University, Franklin College, Butler University and Purdue University.

Lechleiter is a member of the American Chemical Society. He serves as vice chair of the board of the Science History Institute and is an emeritus member of the Central Indiana Corporate Partnership board. Lechleiter also serves on the boards of Ford Motor Company, Indiana Economic Development Corporation, Nike, Inc., and United Way Worldwide.

Patricia (Patty) Martin

President and CEO, BioCrossroads Inc.

Patricia (Patty) Martin joined BioCrossroads as the president and CEO in July 2019. A former Eli Lilly and Company executive, she was the chief operating officer (COO) of Lilly Diabetes for seven years as well as served as Lilly’s Chief Diversity Officer (CDO) and Chief Alliance Officer (CAO). In her 25-year career at Lilly, she also had leadership roles that included strategy, clinical product development, and investor relations.

Martin’s background is a unique breadth of experience integrating science and business. As COO of Lilly Diabetes, she was part of a leadership team that established a vision and strategy that uniquely addressed the increased prevalence and diverse needs of people living with diabetes. During her tenure, Lilly Diabetes launched an unprecedented six new products in 18 months, increasing sales from $6 billion to $8 billion. As CAO, she spearheaded collaborative efforts to ensure the success of Lilly’s partnerships and facilitated cross-functional and cross-disciplinary cooperation to deliver results.

Martin serves on the board of directors of CareSource, Inc. and UltiMed, Inc.

Actively involved in Indianapolis and national non-profit organizations, she is currently a member of the Indiana University Women’s Philanthropy Leadership Council; member of the board of trustees of the Christian Theological Seminary; the Dean’s Advisory Council for the Indiana University Kelley School of Business; and was the board chair for the 500 Festival in 2016. She also serves a board member of the Diabetes Patient Advocacy Coalition.

A graduate of Indiana University, Martin also earned her MBA from the Harvard School of Business.

Dan Peterson

Vice President, Industry & Government Affairs, Cook Group Inc.

Dan Peterson is Vice President, Industry and Government Affairs for Cook Group Incorporated based in Bloomington, Indiana. Since joining Cook in 1989, he has held a variety of leadership roles in the areas of operations, finance/accounting and human resources. Peterson’s current responsibilities involve industry, government and external affairs. His primary areas of focus center on policies and programs in healthcare delivery as well as education, economic and workforce development.

He currently serves as a Commissioner with the Indiana Commission for Higher Education and is a board member of BioCrossroads, the Indiana Biosciences Research Institute, the Indiana Health Industry Forum, the Regional Opportunities Initiative and the Bloomington Economic Development Corporation.

Peterson holds both a Bachelor of Science degree in biology and an MBA in finance from Indiana University.

Since 1963, Cook Group companies have been among the leaders in developing health care devices that have improved lives around the world. Cook has been at the forefront of medical research and product development in Interventional Radiology/Cardiology, Endovascular Medicine, Urology, Women’s Health, GI/Endoscopy, Surgery, Critical Care Medicine and other growing diagnostic and therapeutic practices.

Jon Serbousek

Mid-Tech Industry Advisor, Board Advisor

Jon Serbousek is an advisor to boards of directors and an investor in the med-tech industry. He is past US President of Biomet Orthopedics, WW Group President of Biomet Orthopedics, WW President of Biomet Biologics and Senior Vice President of Biomet, Inc. Prior to joining Biomet, Serbousek held various general management positions with Medtronic, Spine and Biologics, including Worldwide Vice President and General Manager-Biologics, Worldwide Group Division President and Worldwide Division President-Spine.

Before joining Medtronic, Serbousek served as Vice President of Marketing and Product Development for DePuy Orthopedics. He also held the positions of Vice President-Spinal Operations, Vice President and General Manager-Arthroscopy and Sports Medicine and a series of product development and engineering management positions with DePuy.

Serbousek began his career with a Japanese, venture-financed medical device company. During his tenure of working for leading medical device companies, Serbousek had the opportunity to contribute to the generation of over 20 patents.

Serbousek has served on numerous boards of directors for profit and non-profit organizations and currently serves on the board of directors for BioCrossroads, OrthoWorx, the Indiana Biosciences Research Institute, Vesselon and MyoScience. Additionally, he is a member of the University of Memphis’ Herff School of Engineering Advisory Council and Grace College Capital Campaign Cabinet.

Serbousek is a graduate of Washington State University and the University of Utah.

Bill Stephan

Vice President for Engagement, Indiana University

Bill Stephan serves as Indiana University’s Vice President for Engagement and is responsible for coordinating and connecting the university’s vast intellectual and creative resources with strategic opportunities to foster Indiana’s economic growth. Stephan currently oversees all of the university’s functions linked to economic development, technology commercialization, marketing and communications.

In 2000, Stephan joined Indiana University as Assistant Vice President for Economic Development and was subsequently appointed Vice President for University Relations and Corporate Partnerships.

An Indiana native, Stephan is an attorney who served for six years as Chief Magistrate at the Marion Superior Court Juvenile Division. He then joined the administration of former Indianapolis Mayor Stephen Goldsmith where he helped direct social and workforce development policy, served as President and CEO of the Indianapolis Private Industry Council, and later became Chief of Staff and Special Counsel to the Mayor.

Stephan holds a Bachelor of Science degree in economics from Arizona State University and a J.D. from the Indiana University Robert H. McKinney School of Law.